MyFinsight
Home
Blog
About
Contact
Proceeds from issuance of
common shares
$178,884K
Proceeds from issuance of
common shares under...
$132K
Proceeds from maturities
of marketable...
$35,000K
Net cash provided by
financing activities
$179,016K
Net cash provided by
investing activities
$15,212K
Effects of exchange
rates on cash, cash...
$16K
Canceled cashflow
$19,788K
Net increase in
cash, cash...
$44,326K
Canceled cashflow
$149,918K
Non-cash share-based
compensation
$28,286K
Prepaid expenses and
other current and...
-$12,564K
Change in fair value of
notes payable
$3,012K
Depreciation and
amortization
$2,366K
Issuance of common shares
as payment under...
$858K
Purchases of marketable
securities
$19,788K
Net cash used in
operating activities
-$149,918K
Canceled cashflow
$47,086K
Net loss
-$130,532K
Accrued expenses and
other current and...
-$64,414K
Accounts payable
-$1,221K
Other non-cash items,
net
$837K
Back
Back
Cash Flow
Biohaven Ltd. (BHVN)
Biohaven Ltd. (BHVN)
source: myfinsight.com